BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Quercetin, rs3825942, ERBB2, Fatty acid metabolic process, Leukemia, Hypothalamus)
Bookmark Forward

QuickView for Cdk9 (gene)


Body Atlas

Most Correlated Tissues

  1. Leukocyte (polymorphonuclear) of peripheral blood
  2. B lymphocyte (naive) of spleen
  3. Microglial cell
  4. Eosinophil of peripheral blood
  5. T Lymphocyte (regulatory) of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Chronic fatigue syndrome
  2. Disease due to West Nile virus
  3. Pulmonary hypertension
  4. Perforation of tympanic membrane
  5. Disease due to Adenovirus
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Biotin
  2. Tocainide
  3. azaribine
  4. Acyclovir
  5. harman
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ndr1
  2. Ptger4
  3. MUTYH
  4. HK2
  5. SOCS3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. CDK9 keeps RNA polymerase II on track.
  2. The Bur1 cyclin-dependent kinase regulates telomere length in Saccharomyces cerevisiae.
  3. Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.
  4. Bur1 functions with TORC1 for vacuole-mediated cell cycle progression.
  5. Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study of PRT2527 in Patients With Advanced Solid Tumors
  2. Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
  3. A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Met…
  4. A Study of GFH009 in Patients With Hematologic Malignancies
  5. Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.